Mural Oncology PLC (NASDAQ:MURA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Scott Thomas Jackson Other companies: Spero Therapeutics, Inc. (Director · Since at least Apr 16, 2020); MacroGenics, Inc. (Director · Since at least Jan 24, 2017); Crescent Biopharma, Inc. (Director · Nov 27, 2018 – May 1, 2024 · Past); Celator Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 14, 2013 – Jul 12, 2016 · Past) | Director · Since at least Oct 31, 2023 |
| Benjamin Hickey Other companies: Bristol-Myers Squibb Company (President, RayzeBio Org. · Since at least Feb 26, 2024); Surface Oncology Inc (Director · Dec 9, 2021 – Jun 8, 2022 · Past); Halozyme Therapeutics, Inc. (SVP, Chief Commerical Officer · Sep 10, 2018 – Oct 1, 2019 · Past) | Director · Since at least Oct 31, 2023 |
| Adam D Cutler Other companies: InMed Pharmaceuticals Inc. (Director · Nov 12, 2020 – Jan 24, 2022 · Past); Molecular Templates Inc (See remarks · Nov 13, 2017 – Feb 15, 2021 · Past) | Chief Financial Officer · Since at least Nov 15, 2023 |
| Sachiyo Minegishi Other companies: Akouos Inc (Chief Financial Officer · Oct 1, 2020 – Dec 1, 2022 · Past) | Director · Since at least Sep 20, 2024 |
| Caroline Loew | Chief Executive Officer, Director · Since at least Oct 31, 2023 |
| Maiken Keson-Brookes | Chief Legal Officer · Since at least Jul 18, 2025 |
| Vicki L Goodman | Chief Medical Officer · Since at least Nov 10, 2025 |